Kyriakopoulou, 2016 - Google Patents
Quantitative analysis of α-Gal trisaccharide content and its contribution to degeneration of bioprosthetic heart valvesKyriakopoulou, 2016
View PDF- Document ID
- 14478053876058097113
- Author
- Kyriakopoulou K
- Publication year
External Links
Snippet
Background: Commercial bioprosthetic heart valves (BHVs) are generally produced from porcine aortic heart valves or sewn from bovine pericardium. BHVs are durable in older patients, but in younger patients they are subject to age-dependent structural valve …
- 101700016449 GLA 0 title abstract description 224
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Z. Konakci et al. | Alpha‐Gal on bioprostheses: xenograft immune response in cardiac surgery | |
| Ramm et al. | Decellularization combined with enzymatic removal of N‐linked glycans and residual DNA reduces inflammatory response and improves performance of porcine xenogeneic pulmonary heart valves in an ovine in vivo model | |
| US9261518B2 (en) | Method for producing implantable medical bioprostheses having reduced calcification properties | |
| Naso et al. | Alpha‐Gal detectors in xenotransplantation research: a word of caution | |
| McGregor et al. | Physical equivalency of wild type and galactose α 1, 3 galactose free porcine pericardium; a new source material for bioprosthetic heart valves | |
| McGregor et al. | Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves | |
| Lee et al. | Human antibody recognition of xenogeneic antigens (NeuGc and Gal) on porcine heart valves: could genetically modified pig heart valves reduce structural valve deterioration? | |
| US20020127719A1 (en) | Xenograft heart valves | |
| JP2013526889A5 (en) | ||
| Lim et al. | In vivo efficacy of alpha-galactosidase as possible promise for prolonged durability of bioprosthetic heart valve using alpha1, 3-galactosyltransferase knockout mouse | |
| US9006510B2 (en) | Genetically modified heart valve xenografts | |
| Kim et al. | Differences in xenoreactive immune response and patterns of calcification of porcine and bovine tissues in α-Gal knock-out and wild-type mouse implantation models | |
| Human et al. | Residual bioprosthetic valve immunogenicity: forgotten, not lost | |
| Ramm et al. | Decellularized GGTA1-KO pig heart valves do not bind preformed human xenoantibodies | |
| Naso et al. | The α-Gal KO Mouse Animal Model Is a Reliable and Predictive Tool for the Immune-Mediated Calcification Assessment of Heart Valve Bioprostheses | |
| Kyriakopoulou | Quantitative analysis of α-Gal trisaccharide content and its contribution to degeneration of bioprosthetic heart valves | |
| US20090043383A1 (en) | Genetically modified heart valve xenografts | |
| EP3383446B1 (en) | Method for inactivating xenoantigens in biological tissues | |
| Naso et al. | The α-Gal KO Mouse Animal Model is for the Immune-Mediated Calcification Assessment of Heart Valve Bioprostheses | |
| Naso et al. | In-vivo subdermal implant in the alpha-Gal knockout mice model for the assessment of bioprosthetic heart valve calcification rate before and after a polyphenols-based treatment | |
| US12275947B2 (en) | Viable genetically modified sheep with an inactivated alpha-1,3-galactosyltransferase (GGTA1) gene | |
| US20250215450A1 (en) | Viable galactosyltransferase knock-out sheep and related methods | |
| Kang et al. | Development of stromal corneal grafts using a novel decellularization method with sodium cocoyl glutamate on GGTA1/CMAH/β4GalNT2 knock-out porcine corneas | |
| Du Plessis | Mitigation of the inflammatory response to bioprosthetic heart valve tissue through antigen-directed masking | |
| Meyer | Immunology of decellularized allograft tissue used in congenital cardiac surgery |